|
Thimerosal-Containing
Vaccines and
Neurodevelopmental Outcomes
Meeting Agenda
Cambridge, MA
Monday, July 16, 2001
PLEASE NOTE:
Online
presentations from the Thimerosal and Neurodevelopmental Outcomes meeting may
be subject to copyright protection. Permission from the speaker may be
required prior to any copying, reproducing, or rebroadcasting any portion of
the speaker's presentations.
For best results, use
Internet Explorer to view slides.
Welcome and
Introductions
Marie McCormick, MD, ScD
Chair, Immunization Safety
Review Committee
Risk Assessment of
Thimerosal in Childhood Vaccines
Leslie K. Ball, MD
Division of Vaccines and
Related Product Applications
Office of Vaccines Research
and Review
Center for Biologics
Evaluation and Research
Food and Drug Administration
History of Thimerosal
Concern and Comparative Policy Actions
Gary L. Freed, MD
The Percy and Mary Murphy
Professor of Pediatrics and Child Health Delivery
Director, Division of
General Pediatrics
Professor of Health
Management and Policy
University of Michigan
Margie Andreae, MD
Associate Director for
Clinical Services
Division of General
Pediatrics
University of Michigan
Slides
Biologic Plausibility and
Planned Research
Jane M. El-Dahr, MD
Head, Section of Pediatric
Allergy, Immunology, Rheumatology
Tulane University Health Sciences
Center
Slides
David S. Baskin, MD
Professor of Neurosurgery
Baylor College of Medicine
Slides
The Role of Heavy Metals
in Autism
Jeffrey Bradstreet, MD
Director of Research
The International Autism
Research Center
Slides
Pharmacokinetic Modeling
of Hair Mercury Levels from Thimerosal
David Brown, ScD
Toxicologist and Independent
Consultant
Connecticut
Vaccine Safety Datalink
(VSD) Screening Study and Follow-up Analysis with Harvard Pilgrim Data
Thomas Verstraeten, MD, MSc
EIS Officer, National
Immunization Program
Centers for Disease Control
and Prevention
Slides
Protocol for National
Immunization Program Study on Thimerosal
Paul Stehr-Green, DrPH, MPH
Associate Professor of
Epidemiology
University of Washington
School of Community Medicine and Public Health
Slides
William Thompson, PhD (for
Q&A period only)
Epidemiologist, National
Immunization Program
Centers for Disease Control
and Prevention
Seychelles Islands Study
Gary Myers, MD
Professor of Neurology and
Pediatrics
University of Rochester
School of Medicine and Dentistry
Slides
Faroe Islands Study
Philippe Grandjean, MD, DMSc
Institute of Community
Health
Odense University, Denmark
In Vitro Studies of
Thimerosal Toxicity
Boyd E. Haley, PhD
Chairman and Professor,
Department of Chemistry
University of Kentucky
Slides
Comparative Toxicology of
Ethyl and Methyl Mercury
George Lucier, PhD
Former Director,
Environmental Toxicology Program
National Institute for
Environmental Health Sciences
Slides
Rising Incidence of
Autism: Association with Thimerosal
Mark F. Blaxill, MBA
Autism Society of America,
Massachusetts Chapter
Slides
NIH Studies on Thimerosal
Polly Sager, PhD
National Institute of
Allergy and Infectious Diseases
National Institutes of
Health
Slides
Wrap-up Commentary on
Thimerosal Risk
From the Perspective of a
Developmental Toxicologist
George Lambert, MD
Environmental and
Occupational Health Sciences Institute
Robert Wood Johnson Medical
School
Slides
Wrap-up Commentary on
Thimerosal Risk from the Perspective of a Pediatric Vaccinologist
Neal Halsey, MD
Professor and Director
Division of Disease Control
Department of International
Health
Johns Hopkins University
Slides
Public comment period
Return to Thimerosal and
Neurodevelopmental Outcomes page
|
